BRCA1 and ovarian carcinoma: This survey was initiated as a result of a collaborative working group of four scientific societies with the aim of understanding the existing resources of Italian molecular and genomic diagnostic laboratories to perform and report BRCA1/2 testing, both germline and somatic, in ovarian cancer patients.